Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011 (2011), Article ID 215057, 6 pages
http://dx.doi.org/10.1155/2011/215057
Clinical Study

Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism

1Department of Pulmonary Medicine, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, Turkey
2Department of Biochemistry, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, Turkey

Received 5 March 2011; Revised 6 April 2011; Accepted 1 May 2011

Academic Editor: Giuseppe Valacchi

Copyright © 2011 Murat Altuntaş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. F. Tapson, “Acute pulmonary embolism,” New England Journal of Medicine, vol. 358, no. 10, pp. 1037–1052, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. Torbicki, A. Perrier, S. Konstantinides et al., “Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC),” European Heart Journal, vol. 29, pp. 2276–2315, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. Z. Goldhaber, “Pulmonary embolism,” Lancet, vol. 363, no. 9417, pp. 1295–1305, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. V. Pengo, A. W. Lensing, M. H. Prins et al., “Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism,” New England Journal of Medicine, vol. 35, pp. 2257–2264, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. M. Keogh, E. Mayer, R. L. Benza et al., “Interventional and surgical modalities of treatment in pulmonary hypertension,” Journal of the American College of Cardiology, vol. 54, supplement 1, pp. S67–S77, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. Pepke-Zaba, “Diagnostic testing to guide the management of chronic thromboembolic pulmonary hypertension: state of the art,” European Respiratory Review, vol. 19, no. 115, pp. 55–58, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. M. Hoeper, E. Mayer, G. Simonneau, and L. J. Rubin, “Chronic thromboembolic pulmonary hypertension,” Circulation, vol. 113, no. 16, pp. 2011–2020, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. I. M. Lang, “Chronic thromboembolic pulmonary hypertension-not so rare after all,” New England Journal of Medicine, vol. 350, no. 22, pp. 2236–2238, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. T. Dinh-Xuan, T. W. Higenbottam, C. A. Clelland et al., “Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease,” New England Journal of Medicine, vol. 324, no. 22, pp. 1539–1547, 1991. View at Google Scholar · View at Scopus
  10. C. J. Cooper, M. J. Landzberg, T. J. Anderson et al., “Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans,” Circulation, vol. 93, no. 2, pp. 266–271, 1996. View at Google Scholar · View at Scopus
  11. R. A. Dweik, “The lung in the balance: arginine, methylated arginines, and nitric oxide,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 292, no. 1, pp. L15–L17, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. H. Böger, S. M. Bode-Böger, K. Sydow, D. D. Heistad, and S. R. Lentz, “Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 6, pp. 1557–1564, 2000. View at Google Scholar · View at Scopus
  13. J. G. Ray, “Meta-analysis of hyperhomocysteinemia as a risk factor for deep-vein thrombosis,” New England Journal of Medicine, vol. 334, no. 12, pp. 759–762, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. Robinson, K. Arheart, H. Refsum et al., “European COMAC Group. Low circulating folate and vitamin B6 concentrations:risk factors for stroce, peripheral vascular disease, and coranary artery disease,” Circulation, vol. 97, pp. 437–443, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. N. Skoro-Sajer, F. Mittermayer, A. Panzenboeck et al., “Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 11, pp. 1154–1160, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. N. K. Cortas and N. W. Wakid, “Determination of inorganic nitrate in serum and Ürine by a kinetic cadmium-reduction method,” Clinical Chemistry, vol. 3618, pp. 1440–1443, 1990. View at Google Scholar · View at Scopus
  17. J. P. Cooke, “A novel mechanism for pulmonary arterial hypertension,” Circulation, vol. 108, no. 12, pp. 1420–1421, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. C. Stühlinger, P. S. Tsao, J. H. Her, M. Kimoto, R. F. Balint, and J. P. Cooke, “Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine,” Circulation, vol. 104, no. 21, pp. 2569–2575, 2001. View at Google Scholar · View at Scopus
  19. G. Warwick, P. S. Thomas, and D. H. Yates, “Biomarkers in pulmonary hypertension,” European Respiratory Journal, vol. 32, no. 2, pp. 503–512, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Meysman, M. Diltoer, H. D. Raeve, I. Monsieur, and L. Huyghens, “Chronic thromboembolic pulmonary hypertension and vascular transformation of the lymph node sinuses,” European Respiratory Journal, vol. 10, no. 5, pp. 1191–1193, 1997. View at Google Scholar · View at Scopus
  21. R. Sacks, C. V. Remillard, N. Agange, W. R. Auger, P. A. Thistlethwaite, and J. X. J. Yuan, “Molecular biology of chronic thromboembolic pulmonary hypertension,” Seminars in Thoracic and Cardiovascular Surgery, vol. 18, no. 3, pp. 265–276, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. I. Lang and K. Kerr, “Risk factors for chronic thromboembolic pulmonary hypertension,” Proceedings of the American Thoracic Society, vol. 3, no. 7, pp. 568–570, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. T. Kielstein, S. M. Bode-Böger, G. Hesse et al., “Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 7, pp. 1414–1418, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. P. Valtonen, J. Karppi, K. Nyyssönen, V. P. Valkonen, T. Halonen, and K. Punnonen, “Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 828, no. 1-2, pp. 97–102, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. R. Lentz, N. R. Rodinov, and D. Sanjana, “Hyperhomocyteinemia, endothelial dysfonction, and cardiovascular risk: the potential role of ADMA,” Atherosclerosis, vol. 4, pp. 61–65, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. P. Vallance and J. Leiper, “Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 6, pp. 1023–1030, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. Y. Song, N. R. Cook, C. M. Albert, M. Van Denburgh, and J. E. Manson, “Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial,” Diabetes, vol. 58, no. 8, pp. 1921–1928, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus